does medicare pay for glp 1 The GLP-1 Bridge Begins July 1, 2026: What Our Patients Need to Know 💉 Thinking about a GLP-1

The Diet and Nutrition Genetic Report translates your results into personalized, actionable guidance

Why is Medvi considered the best program overall

* From the authors: Thanks to Jeff Levin-Scherz, MD MBA, and Chantell Sell Reagan, PharmD, for their review and contributions.

A comprehensive medical weight loss program should offer FDA-approved anti-obesity medications including GLP-1 receptor agonists (semaglutide, liraglutide, tirzepatide), phentermine and phentermine/topiramate, naltrexone/bupropion, and orlistat

Legal Disclaimer: *These statements have not been evaluated by the FDA

The Bridge Program is a temporary demonstration project running from July 1, 2026, through December 2027